S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
NYSE:STE

STERIS (STE) Stock Price, News & Analysis

$200.71
+0.47 (+0.23%)
(As of 04/18/2024 ET)
Today's Range
$198.22
$201.74
50-Day Range
$198.94
$236.03
52-Week Range
$180.54
$254.00
Volume
658,479 shs
Average Volume
462,762 shs
Market Capitalization
$19.83 billion
P/E Ratio
35.15
Dividend Yield
1.04%
Price Target
$239.60

STERIS MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
19.4% Upside
$239.60 Price Target
Short Interest
Bearish
2.72% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.57mentions of STERIS in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.80%
From $8.67 to $9.52 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.41 out of 5 stars

Medical Sector

100th out of 918 stocks

Surgical Appliances & Supplies Industry

6th out of 18 stocks

STE stock logo

About STERIS Stock (NYSE:STE)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STE Stock Price History

STE Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Steris: Moving On, Losing Its Teeth
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Quant Ratings Updated on 33 Stocks
STE Mar 2024 190.000 call
Why Steris (STE) is a Top Growth Stock for the Long-Term
What 4 Analyst Ratings Have To Say About Steris
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/07/2024
Ex-Dividend for 3/22 Dividend
2/22/2024
Dividend Payable
3/22/2024
Today
4/18/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
CUSIP
85915210
Employees
17,100
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$239.60
High Stock Price Target
$265.00
Low Stock Price Target
$215.00
Potential Upside/Downside
+19.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Net Income
$107.03 million
Pretax Margin
12.62%

Debt

Sales & Book Value

Annual Sales
$4.96 billion
Cash Flow
$18.99 per share
Book Value
$61.31 per share

Miscellaneous

Free Float
97,875,000
Market Cap
$19.79 billion
Optionable
Optionable
Beta
0.79

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Should I Buy STERIS Stock? STE Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in STERIS plc:

  • STERIS plc reported earnings per share (EPS) of $2.22 for the last quarter, beating the consensus estimate by $0.05. This indicates strong financial performance and potential for growth.
  • The company has a market capitalization of $21.78 billion, showcasing its size and stability in the market.
  • STERIS plc operates in the surgical appliances & supplies industry, which has a consistent demand for its products and services, especially in healthcare settings.
  • Recent institutional investments from firms like Vanguard Group Inc. and BlackRock Inc. indicate confidence in the company's future prospects.
  • Despite a recent 3.7% decrease in stock price, STERIS plc has a 1-year high of $254.00, suggesting potential for stock price recovery and growth.

Cons

Investors should be bearish about investing in STERIS plc for these reasons:

  • The company's stock price recently experienced a 3.7% decline, indicating short-term volatility that may concern some investors.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STE Stock Analysis - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" STE shares.
View STE analyst ratings
or view top-rated stocks.

What is STERIS's stock price target for 2024?

6 analysts have issued twelve-month target prices for STERIS's stock. Their STE share price targets range from $215.00 to $265.00. On average, they anticipate the company's share price to reach $239.60 in the next twelve months. This suggests a possible upside of 19.4% from the stock's current price.
View analysts price targets for STE
or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2024?

STERIS's stock was trading at $219.85 at the beginning of the year. Since then, STE stock has decreased by 8.7% and is now trading at $200.71.
View the best growth stocks for 2024 here
.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our STE earnings forecast
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) released its quarterly earnings results on Wednesday, February, 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping analysts' consensus estimates of $2.17 by $0.05. The medical equipment provider had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. STERIS had a net margin of 10.48% and a trailing twelve-month return on equity of 13.67%. STERIS's quarterly revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.02 earnings per share.
Read the conference call transcript
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Tuesday, January 30th. Investors of record on Friday, February 23rd will be paid a dividend of $0.52 per share on Friday, March 22nd. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date is Thursday, February 22nd.
Read our dividend analysis for STE
.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 1.05%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 36.43%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 21.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of 8.600-8.700 for the period, compared to the consensus earnings per share estimate of 8.670. The company issued revenue guidance of $5.5 billion-$5.5 billion, compared to the consensus revenue estimate of $5.4 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Who are STERIS's major shareholders?

STERIS's stock is owned by many different retail and institutional investors. Top institutional investors include Congress Asset Management Co. MA (0.63%), Artemis Investment Management LLP (0.18%), Congress Wealth Management LLC DE (0.12%), Running Oak Capital LLC (0.05%), Perpetual Ltd (0.04%) and Global Assets Advisory LLC (0.03%). Insiders that own company stock include Cary L Majors, Cynthia L Feldmann, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi and Renato Tamaro.
View institutional ownership trends
.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:STE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners